The Innovative Medicines Initiative (IMI) has announced its 9th call for proposals, targetting over €135m in funding at industry/academic collaborations to overcome research bottle-necks in the drug development process.
The topics included in the 9th Call are:
- WEBAE – Leveraging emerging technologies for pharmacovigilance
- Developing innovative therapeutic interventions against physical frailty and sarcopenia (ITI-PF&S) as a prototype geriatric indication
- Driving re-investment in R&D and responsible use of antibiotics
- Clinical development of antibacterial agents for Gram-negative antibiotic resistant pathogens
Submissions must be made by October 9th, and the IMI Partner Search Tool will enable teams to find potential collaborators for projects.